
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Medical-care expenditures have been rising rapidly, accounting for almost one-Öfth of GDP in 2009. In this study, we assess the sources of the rising medical-care expenditures in the commercial sector. We employ a novel framework for decomposing expenditure growth into four components at the disease level: service price growth, service utilization growth, treated disease prevalence growth, and demographic shift. The decomposition shows that growth in prices and treated prevalence are the primary drivers of medical-care expenditure growth over the 2003 to 2007 period. There was no growth in service utilization at the aggregate level over this period. Price and utilization growth were especially large for the treatment of malignant neoplasms. For many conditions, treated prevalence has shifted towards preventive treatment and away from treatment for late-stage illnesses.
This study investigates the primary drivers behind the escalating costs of medical care within the commercial sector. The research employs a novel framework to dissect expenditure growth into four key components at the disease level: service price growth, service utilization growth, treated disease prevalence growth, and demographic shifts. Analysis of data from 2003 to 2007 reveals that increases in prices and treated prevalence were the principal forces behind rising medical-care expenditures, with no aggregate growth in service utilization during this period. Specific attention is given to the significant price and utilization growth observed in the treatment of malignant neoplasms.
This academic study offers a rigorous quantitative analysis of medical-care expenditure growth, focusing on a specific period and sector. The methodology, which decomposes growth into distinct components at the disease level, provides a granular understanding of cost drivers. The findings highlight the significant impact of price increases and the expansion of treated prevalence as key contributors to rising healthcare costs. The research suggests that while overall service utilization remained stable, specific treatments, such as those for malignant neoplasms, experienced notable increases in both price and utilization.
Page Count:
34
Publication Date:
2013-02-08
Publisher:
BiblioGov
ISBN-10:
1288726260
ISBN-13:
9781288726264
No comments yet. Be the first to share your thoughts!